GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, will present additional data from both the NHS-Galleri trial and the PATHFINDER 2 study further ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Hofstra University student Linden Faye ’27 has been awarded the Barry Goldwater Scholarship, a highly competitive national ...

At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.

Liver scarring can pave the way to cancer down the line. A new blood test in development might help doctors spot it.

A recent study published in Cell Reports Medicine has identified distinct microbial "signatures" within the oral cavity and gut that serve as robust biomarkers for the early detection of gastric ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

A skin cancer diagnosis can seem to arrive out of nowhere. But buried in years of health records, prescription histories, and ...

WHAT: Researchers from the Johns Hopkins Kimmel Cancer Center will present new research findings and receive honors and ...

Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...